Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Vascular Ulcers Treatment & Management

  • Author: Allen Gabriel, MD, FACS; Chief Editor: Joseph A Molnar, MD, PhD, FACS  more...
 
Updated: Mar 16, 2016
 

Medical Therapy

The latest research on wound care has resulted in increased use of interactive and active dressings rather than passive dressings that cover and absorb. Interactive hydrocolloid dressings provide a controlled microenvironment for wound healing. Active dressings deliver substances such as growth factors, which are important in the healing cascade.

Interactive dressings are typically occlusive dressings. They provide important moisture and supply a favorable microenvironment for the growth of new tissue. The advantages of moist occlusive dressings are numerous. Exudate is controlled, while epithelial cell migration is encouraged. Eschar is liquefied and fibrin is lysed to allow convenient debridement. Infection is managed through wound fluid rich in leukocytes. These dressings are also believed to provide symptomatic relief, such as decreased pain and pruritus.

Dressings that deliver substances active in the healing process, such as growth factors, have been the subject of much recent investigation. While normal wounds heal because of epidermal division and migration within a neovascularized mesh of granulation tissue, resulting in a cover of new skin, chronic wounds typically show inadequate repair due to insufficient perfusion or wound infection.

Wounds caused by venous hypertension are commonly treated with multilayer compression dressings that assist the return of pooled blood to the central circulation. These dressings have shown good results, with 73% of wounds healing with no other intervention needed.[10]

A randomized, controlled study by Ashby et al suggested that two-layer compression hosiery is as effective as four-layer bandages in the treatment of venous leg ulcers and may reduce the incidence of ulcer recurrence. The study involved 457 adult patients with venous leg ulcers, all of whom were able to tolerate high compression. The investigators found that the time required for ulcers to heal was the same for both compression modalities. However, it took less time for ulcers to recur in the bandage group than in the group treated with compression hosiery.[11]

Topically applied growth factors are meant to assist the chronic wound with establishing healthy granulation tissue or epidermal cell function for improved healing. Several growth factors have been studied to this end. Platelet-derived growth factor has been shown to reduce the size of chronic ulcers by up to 70%, as compared to 17% for placebo, probably via acceleration of provisional wound matrix deposition. Epidermal growth factor supplementation was associated with healing of 8 of 9 wounds in which therapy had previously failed. Fibroblast growth factor has also been studied, but positive results have not yet been achieved.

Chronic wounds may be associated with active infection, such as cellulitis. Additionally, an occasional chronic wound may be the nidus for bacteremia and sepsis. In these cases, administer systemic antibiotics. Alternatively, the wound itself may be infected, without systemic effects. Take steps to lower the bacterial count of these wounds, including topical methods to encourage wound healing.

Edlich et al have shown that dressing changes alone usually lower the bacterial load, regardless of the type.[12] Silver sulfadiazine has been shown to almost universally reduce the bacterial load to levels acceptable for wound closure. It is a broad-spectrum antibiotic and does not cause pain, as has been noted with mafenide acetate (Sulfamylon). However, penetration of eschar is questionable with this antibiotic. Saline-dampened gauze dressing changes also reduce the bacterial load in the large majority of wounds, but not as effectively as silver sulfadiazine. Povidone-iodine solution (Betadine) has also been used as a topical antibiotic and is largely successful at reducing bacterial counts. However, a widely held belief is that this solution also kills granulation tissue, which significantly impairs healing of these wounds.

New investigations have focused on nonsurgical methods of improving the microcirculation of the healing wound. The use of low-intensity ultrasonic stimulation of venous ulcers has shown a significant improvement in the rate of wound healing from 29% in a control group to 63% in the experimental group. This increased rate of healing is thought to be mediated by stimulation of signal-transduction pathways directly involved in angiogenesis, leukocyte adhesion, and growth factor production.[13]

The results of a Cochrane Database of Systematic Reviews study found that intermittent pneumatic compression (IPC) may increase healing compared with no compression in the treatment of venous leg ulcers and limb swelling due to lymphedema. Further trials are needed to determine whether IPC increases healing when used in conjunction with bandage treatment or if it can be used as an alternative to compression bandages.[14]

Even though hyperbaric oxygen therapy is considered an important adjunct in wound healing, it is always important to revisit the evidence in the literature. The authors of a recent Cochrane summary reviewed relevant trials and concluded that in people with foot ulcers due to diabetes, hyperbaric oxygen therapy significantly improves ulcer healing in the short term but not in the long term. More studies are needed to properly evaluate hyperbaric oxygen therapy in patients with chronic wounds.[15]

Investigations have highlighted the possibility of using injected low molecular weight heparin to speed healing in neurotrophic ulcers in the setting of occlusive peripheral artery disease. The rationale for this therapy is to improve the microcirculation of the healing wound by thinning the blood and increasing the flow of capillary flow of blood to the injured tissues. Data published by Kalani et al show 67% wound healing in patients treated with dalteparin compared to 47% healing in individuals treated with placebo.[16] This medication also showed benefit in a lower rate of amputation, from 19% amputation rate in the placebo group to 5% rate of amputation in the dalteparin group.[16] Oral therapies under investigation reportedly decrease the symptoms of chronic venous insufficiency but remain experimental at this time.[17]

Next

Surgical Therapy

When considering surgical therapy for chronic vascular ulcers, consider which is more appropriate for the patient: (1) revascularization and/or coverage of the wound, (2) ligation of incompetent venous perforators, or (3) primary amputation and rehabilitation. The plastic surgeon has several options when choosing operative coverage of an ulcer.

As always, basic surgical principles should be followed. All chronic wounds need to be debrided to convert them into an acute wound to allow for the normal wound healing cycle to resume. In addition, a formal debridement removes the biofilm that has been built up during the chronic phase. The colonized bacteria are removed and cytoprotective cytokines are secreted to start the inflammatory phase of wound healing.

When the ulcer is caused by venous reflux in the superficial venous system, the problem can be addressed with minimally invasive procedures commonly practiced by vascular surgeons. These surgeries include saphenofemoral junction disconnection, stripping of the long saphenous vein to below the knee, calf varicosity avulsions, or saphenopopliteal junction disconnection. The rate of wound healing for those treated with surgery is not significantly higher than that of patients who are treated conservatively, but the resultant diminished rate of wound recurrence is a benefit.[10]

Ligation of superficial venous perforators has been shown to reduce the 4-year recurrence rate of vascular ulcers, from 56% in ulcers treated by compression alone to 31% in ulcers treated by compression plus surgery (P < .01).[18] This is a tremendous leap forward, as the natural history of these wounds is one of frequent recurrence. In the case of ulcers not caused by venous hypertension, other approaches must be considered.

A literature review by de Carvalho, however, found that three of the four studies used in the review reported healing rates for venous leg ulcers treated with compression therapy alone to be the same as those for ulcers managed with a combination of compression and surgery. Moreover, although most of the studies found a lower rate of recurrence for venous ulcers treated with the compression/surgery combination versus with compression alone, the difference was not statistically significant.[19]

Revision of the wound followed by split-thickness skin graft (STSG) has long been an option for chronic wound management. Once a clean, granulating wound bed has been established through debridement, placement of a skin graft is usually all that is required to attain closure. Skin grafting can be effective for coverage of venous ulcers, but attention must be paid to extremity elevation during healing. Ischemic wounds located in areas that are difficult to treat also may be closed with skin grafting; studies have reported closure rates of 40% for diabetic foot wounds.

Often, the wound bed is not suitable for grafting or a structure such as a bone or tendon is exposed. Under these circumstances, consider pedicled or free flaps. These flaps are desirable for several reasons. Healing is promoted even in a suboptimal bed. All diseased tissue, including bone, may be debrided or excised. Neovascularization of the ischemic bed from the flap may occur, and vascular graft patency may be improved by the vascular runoff provided by free tissue transfer.

Microvascular flap coverage of chronic ulcers has met with much success in the treatment of arterial ulcers. Colen performed 10 such transfers in patients with peripheral vascular disease; 7 of these patients had revascularization prior to the procedure.[20] All anastomoses were successful, although 1 patient underwent amputation after sepsis and its cardiovascular sequelae. Ciresi and coworkers reported successful salvage of limb length and function in 5 of 7 patients who underwent free tissue transfer for ischemic ulcers.[21]

Recently, plastic surgeons have begun treating venous ulcers with free tissue transfer, with mixed results. Steffe and Caffee report a 43% complication rate after tissue transfer to venous wounds and the development of new ulcers in all patients at approximately 17 months.[22] Alternatively, Kumins et al[23] and Weinzweig and Schuler[24] reported good success using free muscle flaps and skin grafting to cover venous ulcers. In the first study, all ulcers were healed, and the second study reports a 90% success rate. Both studies were notable for a low recurrence of ulceration and an acceptable complication rate.

The use of negative pressure wound therapy has also been used in these wounds. This can help twofold. First, the wound can be temporized while waiting for additional studies to determine the etiology of disease or while optimizing the patient (ie, optimizing intrinsic, extrinsic, and iatrogenic factors); second, this therapy can serve as destination therapy or a bridging therapy to surgery. In addition, if a wound is skin grafted, negative pressure wound therapy (VAC therapy, KCI) should be used for improved take of the graft.[25]

Previous
Next

Preoperative Details

Familiarity with the perfusion and vascular supply to the lower extremity is critical to the surgeon for operative planning. Studies estimating perfusion can help predict healing of the wound or flap. Specific knowledge of the arterial supply is invaluable when performing either pedicled or free tissue transfer. Angiography yields detailed visualization of the vessels. Colen and Musson advocate using duplex imaging to select both the recipient vessel and the region of the vessel most suitable for vascular anastomosis.[26]

Previous
Next

Intraoperative Details

Normally, vascular ulcers are treated conservatively with nonoperative techniques. When treated surgically, STSG to the affected areas is the usual procedure.

Applying a skin graft to a vascular ulcer requires the same techniques as grafting to other wounds or burns. Varying degrees of ulcer debridement may be required prior to grafting.

Harvest a graft from an area of healthy tissue; it may be left in its contracted state or meshed for greater surface-area coverage. Then, apply the graft to the clean, granulating ulcer. It may be secured in place using sutures or skin staples. Grafts also adhere without suturing or stapling if protected well from disruptive forces.

Pedicled and free flaps also may be used for coverage of a vascular ulcer. A wide array of choices may be used, based on the location of the ulcer and the status of the vessels perfusing the various pedicled flaps. The patency of the vessel providing inflow for a free flap is also a consideration. The details for performing flap coverage of a chronic ulcer are best studied in a text dedicated to tissue flaps (eg, Flaps, Random Skin Flaps).

Previous
Next

Complications

The greatest risk of complications in surgical coverage of vascular ulcers lies with tissue transfer. An obvious source of postoperative concern with regard to successful free tissue transfer is the vascular supply to the flap. The rate of vascular complications in flaps transferred to vascularly compromised tissue is not known, but Rieck et al report a 16% rate of vascular complications out of 631 cases of free tissue transfers.[27] Yajima et al experienced 39 complications in 250 similar cases.[28]

The complication rate in patients with ischemic ulcers is expected to be higher than these rates because of the patients' primary diseases. Indeed, Lepantalo and Tukiainen observed vascular patency rates of 68% in their study.[29] Ciresi et al report minor wound complications in 4 of 7 patients studied.[21]

Complication rates among cases of tissue transfer for venous ulceration are less well defined. Weinzweig and Schuler report a loss of 2 of 20 flaps, both due to vasospasm, although one occurred in a patient with a history of cocaine abuse.[24] They also noted 3 cases of infection with partial flap and/or graft loss and 2 cases of partial graft loss. Steffe and Caffee experienced a loss of 2 of 14 flaps, caused by venous thrombosis.[22] Two patients had partial flap necrosis in their study, while another 2 had partial graft loss.

Previous
Next

Outcome and Prognosis

Care of chronic ulcers can be accomplished by an array of medical and surgical modalities. Regardless of the method of choice, the primary goal of treating vascular ulcers is preservation of limb length and function. The etiology of the patient's disease and the choice of treatment both play an important role in reaching a successful outcome. The patient's goals and expectations should be taken into account, and the approach should be multidisciplinary in nature.

Finally, practitioners must understand that without adequate perfusion to the extremity, healing stalls at a chronic inflammatory phase. For wound healing to advance to the next phase of the cycle, adequate perfusion to the wound should be present, which is essential in delivering the appropriate proliferative and remodeling cells and cytokines necessary for healing. In addition, nutrition and oxygen are delivered for pertinent biochemical reactions to take place locally. The wound healing market is saturated with many "potions," but the clinician must rely on his or her own discretion to understand the underlying pathophysiology and recommend optimal care.

Previous
 
Contributor Information and Disclosures
Author

Allen Gabriel, MD, FACS Assistant Professor, Department of Plastic Surgery, Loma Linda University School of Medicine

Allen Gabriel, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, California Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Christian E Paletta, MD, FACS Clinical Professor of Surgery and Instructor of Surgery, Department of Surgery, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth; Clinical Professor of Surgery and Instructor in Surgery, Rwanda Human Resources for Health, Rwanda Ministry of Health and Clinton Health Access Initiative

Christian E Paletta, MD, FACS is a member of the following medical societies: American Society of Plastic Surgeons, Plastic Surgery Research Council, American Council of Academic Plastic Surgeons, American College of Surgeons, American Medical Association

Disclosure: Nothing to disclose.

Brandon Massey, MD Staff Physician, Department of Plastic and Reconstructive Surgery, St Louis University School of Medicine

Disclosure: Nothing to disclose.

Matthew C Camp, MD Resident Surgeon, Department of Plastic Surgery, Loma Linda University Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Wayne Karl Stadelmann, MD Stadelmann Plastic Surgery, PC

Wayne Karl Stadelmann, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society of Plastic Surgeons, New Hampshire Medical Society, Northeastern Society of Plastic Surgeons, Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Joseph A Molnar, MD, PhD, FACS Medical Director, Wound Care Center, Associate Director of Burn Unit, Professor, Department of Plastic and Reconstructive Surgery and Regenerative Medicine, Wake Forest University School of Medicine

Joseph A Molnar, MD, PhD, FACS is a member of the following medical societies: American Medical Association, American Society for Parenteral and Enteral Nutrition, American Society of Plastic Surgeons, North Carolina Medical Society, Undersea and Hyperbaric Medical Society, Peripheral Nerve Society, Wound Healing Society, American Burn Association, American College of Surgeons

Disclosure: Received grant/research funds from Clinical Cell Culture for co-investigator; Received honoraria from Integra Life Sciences for speaking and teaching; Received honoraria from Healogics for board membership; Received honoraria from Anika Therapeutics for consulting; Received honoraria from Food Matters for consulting.

References
  1. Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle). 2015 Sep 1. 4 (9):560-582. [Medline]. [Full Text].

  2. O'Brien JF, Grace PA, Perry IJ, et al. Prevalence and aetiology of leg ulcers in Ireland. Ir J Med Sci. 2000 Apr-Jun. 169(2):110-2. [Medline].

  3. Perrotto J, Glick B. Lower extremity malignancies masquerading as ulcers. Ostomy Wound Manage. 2006 Oct. 52(10):46-52. [Medline].

  4. Labropoulos N, Manalo D, Patel NP, et al. Uncommon leg ulcers in the lower extremity. J Vasc Surg. 2007 Mar. 45(3):568-573. [Medline].

  5. Lane RJ, Cuzzilla ML, Harris RA, Phillips MN. Popliteal vein compression syndrome: obesity, venous disease and the popliteal connection. Phlebology. 2009 Oct. 24(5):201-7. [Medline].

  6. Rasmussen JC, Aldrich MB, Tan IC, et al. Lymphatic transport in patients with chronic venous insufficiency and venous leg ulcers following sequential pneumatic compression. J Vasc Surg Venous Lymphat Disord. 2016 Jan. 4 (1):9-17. [Medline].

  7. Yucel EK, Dumoulin CL, Waltman AC. MR angiography of lower-extremity arterial disease: preliminary experience. J Magn Reson Imaging. 1992 May-Jun. 2(3):303-9. [Medline].

  8. Owen RS, Carpenter JP, Baum RA, et al. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med. 1992 Jun 11. 326(24):1577-81. [Medline].

  9. Neglén P, Raju S. A rational approach to detection of significant reflux with duplex Doppler scanning and air plethysmography. J Vasc Surg. 1993 Mar. 17(3):590-5. [Medline].

  10. van Gent WB, Hop WC, van Praag MC, et al. Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicenter trial. J Vasc Surg. 2006 Sep. 44(3):563-71. [Medline].

  11. Ashby RL, Gabe R, Ali S, et al. VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model. Health Technol Assess. 2014 Sep. 18(57):1-293, v-vi. [Medline].

  12. Edlich RF, Rogers W, Kasper G, et al. Studies in the management of the contaminated wound. I. Optimal time for closure of contaminated open wounds. II. Comparison of resistance to infection of open and closed wounds during healing. Am J Surg. 1969 Mar. 117(3):323-9. [Medline].

  13. Kavros SJ, Miller JL, Hanna SW. Treatment of ischemic wounds with noncontact, low-frequency ultrasound: the Mayo clinic experience, 2004-2006. Adv Skin Wound Care. 2007 Apr. 20(4):221-6. [Medline].

  14. Nelson EA, Mani R, Thomas K, Vowden K. Intermittent pneumatic compression for treating venous leg ulcers. Cochrane Database Syst Rev. 2011 Feb 16. 2:CD001899. [Medline].

  15. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2012 Apr 18. 4:CD004123. [Medline].

  16. Kalani M, Apelqvist J, Blombäck M, et al. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care. 2003 Sep. 26(9):2575-80. [Medline].

  17. Cesarone MR, Belcaro G, Rohdewald P, et al. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study. Clin Appl Thromb Hemost. 2006 Apr. 12(2):205-12. [Medline].

  18. Gohel MS, Barwell JR, Taylor M, et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. BMJ. July 2007. 335:7610. [Medline].

  19. de Carvalho MR. Comparison of outcomes in patients with venous leg ulcers treated with compression therapy alone versus combination of surgery and compression therapy: a systematic review. J Wound Ostomy Continence Nurs. 2015 Jan-Feb. 42 (1):42-6; quiz E1-2. [Medline].

  20. Colen LB. Limb salvage in the patient with severe peripheral vascular disease: the role of microsurgical free-tissue transfer. Plast Reconstr Surg. 1987 Mar. 79(3):389-95. [Medline].

  21. Ciresi KF, Anthony JP, Hoffman WY, et al. Limb salvage and wound coverage in patients with large ischemic ulcers: a multidisciplinary approach with revascularization and free tissue transfer. J Vasc Surg. 1993 Oct. 18(4):648-53; discussion 653-5. [Medline].

  22. Steffe TJ, Caffee HH. Long-term results following free tissue transfer for venous stasis ulcers. Ann Plast Surg. 1998 Aug. 41(2):131-7; discussion 138-9. [Medline].

  23. Kumins NH, Weinzweig N, Schuler JJ. Free tissue transfer provides durable treatment for large nonhealing venous ulcers. J Vasc Surg. 2000 Nov. 32(5):848-54. [Medline].

  24. Weinzweig N, Schuler J. Free tissue transfer in treatment of the recalcitrant chronic venous ulcer. Ann Plast Surg. 1997 Jun. 38(6):611-9. [Medline].

  25. Gupta S, Gabriel A, Shores J. The perioperative use of negative pressure wound therapy in skin grafting. Ostomy Wound Manage. 2004 Nov. 50(11A Suppl):26S-28S. [Medline].

  26. Colen L, Musson A. Preoperative assessment of the peripheral vascular disease patient for free tissue transfers. J Reconstr Microsurg. 1987 Oct. 4(1):1-14. [Medline].

  27. Rieck B, Mailander P, Machens HG. Vascular complications after free tissue transfer. Microsurgery. 1995. 16(6):400-3. [Medline].

  28. Yajima H, Tamai S, Mizumoto S, et al. Vascular complications of vascularized composite tissue transfer: outcome and salvage techniques. Microsurgery. 1993. 14(8):473-8. [Medline].

  29. Lepantalo M, Tukiainen E. Combined vascular reconstruction and microvascular muscle flap transfer for salvage of ischaemic legs with major tissue loss and wound complications. Eur J Vasc Endovasc Surg. 1996 Jul. 12(1):65-9. [Medline].

  30. Wipke-Tevis DD, Sae-Sia W. Caring for vascular leg ulcers. Home Healthc Nurse. 2004 Apr. 22(4):237-47; quiz 248-9. [Medline].

 
Previous
Next
 
Vascular ulcers. Arterial ulcer with characteristic features.
Vascular ulcers. Venous ulcer with characteristic features.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.